Product
BioThrax
Aliases
Anthrax Vaccine Adsorbed, Anthrax Vaccine Adsorbed (AVA), AVA
5 clinical trials
2 indications
Indication
AnthraxIndication
Anthrax InfectionClinical trial
A Phase 3, Randomized, Double-blind, Parallel-group Trial to Evaluate the Lot Consistency, Immunogenicity, and Safety of AV7909 for Postexposure Prophylaxis of Anthrax in Healthy AdultsStatus: Completed, Estimated PCD: 2020-08-06
Clinical trial
A Parallel-arm, Double-blind, Randomized, Placebo-controlled, Dose-ranging Clinical Trial Evaluating the Safety, Tolerability and Immunogenicity of AV7909 in Healthy AdultsStatus: Completed, Estimated PCD: 2012-05-01
Clinical trial
A Phase 2, Randomized, Parallel-Group, Active-Controlled, Double-Blind Study to Evaluate the Safety and Immunogenicity of AV7909 for Post-Exposure Prophylaxis of Anthrax Using Three Immunization Schedules and Two Dose Levels in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2014-02-01
Clinical trial
A Study of The Effects of Co-Administering Ciprofloxacin and BioThrax on the Pharmacokinetics of Ciprofloxacin in Healthy AdultsStatus: Completed, Estimated PCD: 2013-08-01
Clinical trial
Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy AdultsStatus: Completed, Estimated PCD: 2012-05-01